← The Wire
IRWDNasdaq
IRONWOOD PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1446847
Develops and commercializes life-changing therapies for gastrointestinal and rare diseases
red 8-K · 90d
$601M
Market cap
$4.30
Last close
+4.1%
1D
+12.6%
5D
3.5M
Volume
Price · last 39 sessions-6.3%
May 4L $3.22 · H $4.83Jun 29
236
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 18, 20268-KCompany UpdateJun 15, 20268-K/AExecutive ChangeMay 21, 20268-KExecutive ChangeMay 13, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 2026SC 13D/ASC 13D/AMar 19, 20268-KCompany UpdateMar 11, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 25, 20268-KResults of OperationsJan 2, 20268-KMaterial Agreement · Company UpdateDec 23, 20258-KCompany UpdateNov 26, 20258-KResults of OperationsNov 10, 202510-Q10-QNov 10, 20258-KExecutive ChangeOct 10, 20258-KCompany UpdateSep 3, 202510-Q10-QAug 11, 20258-KResults of OperationsAug 7, 20258-KAuditor ChangeJul 10, 20258-KShareholder VoteJun 12, 20258-KDelisting NoticeJun 3, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KResults of OperationsApr 25, 20258-KCompany UpdateApr 14, 202510-K10-KMar 31, 20258-KDelisting Notice · Reg FD DisclosureMar 27, 20258-KResults of OperationsFeb 27, 20258-KExecutive Change · Exit / Disposal CostsJan 29, 20258-KExecutive ChangeDec 5, 2024SC 13GSC 13GNov 14, 20248-KExecutive ChangeNov 12, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KMaterial Agreement · New Debt / ObligationSep 30, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KShareholder VoteJun 21, 20248-KExecutive Change · Company UpdateJun 20, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF14AApr 25, 202410-K10-KFeb 16, 20248-KResults of OperationsFeb 15, 20248-KResults of OperationsJan 8, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-K/ACompany UpdateSep 11, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 8, 2023SC 13DSC 13DJul 7, 20238-KAcquisition / Disposition · New Debt / ObligationJun 30, 20238-KExecutive Change · Shareholder VoteJun 22, 20238-KMaterial Agreement · New Debt / ObligationMay 22, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 27, 2023DEF 14AFORM DEF 14AApr 27, 20238-KExecutive ChangeApr 11, 202310-K10-KFeb 16, 20238-KResults of OperationsFeb 16, 2023SC 13GLSV13G123122IRONWOOD.TXTFeb 10, 2023SC 13GSC 13GFeb 2, 20238-KResults of OperationsJan 9, 202310-Q10-QNov 3, 20228-KResults of OperationsNov 3, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 2022SC 13GSC 13GJul 8, 20228-KShareholder VoteJun 3, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 2022DEFA14ADEFA14AApr 21, 2022DEF 14ADEF 14AApr 21, 2022
Insider Activity
In the 90 days to Mar 17, 2026: 7 sold $21.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Denner Alexander JDirector | Sell | 6,725,000 | $3.05 | $20.5M |
| Mar 17, 2026 | Denner Alexander JDirector | Sell | 5,800 | $3.31 | $19K |
| Feb 24, 2026 | Mccourt Thomas AChief Executive Officer | Sell | 103,526 | $3.66 | $379K |
| Feb 24, 2026 | John MinardoChief Legal Officer | Sell | 19,053 | $3.66 | $70K |
| Feb 24, 2026 | Shetzline MichaelSVP, CMO, Head-Res&Drug | Sell | 17,012 | $3.66 | $62K |
| Feb 24, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 12,621 | $3.66 | $46K |
| Feb 24, 2026 | Martini Gregory S.Chief Financial Officer | Sell | 11,457 | $3.66 | $42K |
| Feb 24, 2026 | Gaskins Tammi LChief Commercial Officer | Sell | 11,239 | $3.66 | $41K |
| Feb 23, 2026 | Mccourt Thomas AChief Executive Officer | Sell | 94,757 | $3.81 | $361K |
| Feb 23, 2026 | John MinardoChief Legal Officer | Sell | 17,439 | $3.81 | $66K |
| Feb 23, 2026 | Shetzline MichaelSVP, CMO, Head-Res&Drug | Sell | 15,570 | $3.81 | $59K |
| Feb 23, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 11,552 | $3.81 | $44K |
| Feb 23, 2026 | Martini Gregory S.Chief Financial Officer | Sell | 10,487 | $3.81 | $40K |
| Feb 23, 2026 | Gaskins Tammi LChief Commercial Officer | Sell | 10,287 | $3.81 | $39K |
| Jan 5, 2026 | Silver RonaldPrincipal Accounting Officer | Sell | 35,416 | $4.60 | $163K |
| Nov 17, 2025 | Gaskins Tammi LChief Commercial Officer | Sell | 6,016 | $3.32 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance